Najat Khan | Radical Transformation: Becoming a Medicines Company with End-to-End AI

https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/7a/89/d2/7a89d2eb-58c2-8887-e394-e727c76dc72f/mza_5501671720659720569.jpg/600x600bb.jpg

Talking Precision Medicine

Genialis

51 episodes

15 hours ago

Welcome to the Talking Precision Medicine podcast. In this series, we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host.

Life Sciences

Science

RSS

All content for Talking Precision Medicine is the property of Genialis and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Life Sciences

Science

https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded/1109085/1109085-1591869612639-da4fed0a60a7.jpg

Najat Khan | Radical Transformation: Becoming a Medicines Company with End-to-End AI | TPM #44

Talking Precision Medicine

38 minutes 35 seconds

7 months ago

Najat Khan | Radical Transformation: Becoming a Medicines Company with End-to-End AI | TPM #44

Today’s guest is Najat Khan, Chief R&D Officer and Chief Commercial Officer at Recursion Pharmaceuticals.

Recursion is widely recognized as one of the most visible—and so far, most successful—companies to emerge from the tech-bio movement. Many consider it the current industry leader.

It has become an iconic name in the field of artificial intelligence for drug discovery.

TPM E44 highlights >⁠⁠⁠⁠⁠⁠⁠

Episode 44 links: